日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

 前へ次へ 

公開

学術論文

Fibronectin and its receptors in hematopoiesis

MPS-Authors
/persons/resource/persons244022

Nakchbandi,  Inaam A.
Max Planck Institute for Medical Research, Max Planck Society;

External Resource

https://www.mdpi.com/2073-4409/9/12/2717/pdf
(全文テキスト(全般))

https://www.mdpi.com/2073-4409/9/12/2717
(全文テキスト(全般))

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)
公開されているフルテキストはありません
付随資料 (公開)
There is no public supplementary material available
引用

FranziskaWirth, Lubosch, A., Hamelmann, S., & Nakchbandi, I. A. (2020). Fibronectin and its receptors in hematopoiesis. Cells, 9(12):, pp. 1-16. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33353083/.


引用: https://hdl.handle.net/21.11116/0000-0008-E84A-0
要旨
Fibronectin is a ubiquitous extracellular matrix protein that is produced by many cell types in the bone marrow and distributed throughout it. Cells of the stem cell niche produce the various isoforms of this protein. Fibronectin not only provides the cells a scaffold to bind to, but it also modulates their behavior by binding to receptors on the adjacent hematopoietic stem cells and stromal cells. These receptors, which include integrins such as α4β1, α9β1, α4β7, α5β1, αvβ3, Toll-like receptor-4 (TLR-4), and CD44, are found on the hematopoietic stem cell. Because the knockout of fibronectin is lethal during embryonal development and because fibronectin is produced by almost all cell types in mammals, the study of its role in hematopoiesis is difficult. Nevertheless, strong and direct evidence exists for its stimulation of myelopoiesis and thrombopoiesis using in vivo models. Other reviewed effects can be deduced from the study of fibronectin receptors, which showed their activation modifies the behavior of hematopoietic stem cells. Erythropoiesis was only stimulated under hemolytic stress, and mostly late stages of lymphocytic differentiation were modulated. Because fibronectin is ubiquitously expressed, these interactions in health and disease need to be taken into account whenever any molecule is evaluated in hematopoiesis.